| RS150590027 |
HPS5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 5, Hermansky-Pudlak syndrome 5 |
| RS150590855 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS150591206 |
MITF
|
Health Risk |
Conflicting classifications of pathogenicity |
Waardenburg syndrome type 2A, Tietz syndrome |
| RS150591260 |
MCCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS150592488 |
CFAP418
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 16, Retinitis pigmentosa |
| RS150593522 |
TRAPPC11
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS150593655 |
STAMBP
|
Health Risk |
Likely pathogenic |
STAMBP-related disorder, STAMBP-related disorder |
| RS150593932 |
USH1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1C, Usher syndrome type 1C |
| RS150595411 |
DNAJC12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150595667 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, DOCK8-related disorder |
| RS150596964 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS150596993 |
CCBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 1 |
| RS150597050 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS150597413 |
FLG
|
Health Risk |
Pathogenic/Likely pathogenic |
Ichthyosis vulgaris, Dermatitis |
| RS150598413 |
SBF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4B2, Charcot-Marie-Tooth disease type 4 |
| RS150598773 |
IFITM5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150599325 |
CDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Neurofibromatosis |
| RS150599652 |
TGM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150600286 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150601238 |
UCHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinson disease 5, autosomal dominant |
| RS150601728 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS150602021 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS150602845 |
TSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperthyroidism due to mutations in TSH receptor, Hypothyroidism due to TSH receptor mutations |
| RS150603624 |
HIRA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150603941 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS150604289 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS150606321 |
TEX15
|
Health Risk |
Conflicting classifications of pathogenicity |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS150606453 |
LAMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS150607307 |
TACO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS150607375 |
MEGF8
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF8-related Carpenter syndrome, Inborn genetic diseases |
| RS150607556 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS150607716 |
CNTNAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS150607879 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, SPTBN2-related disorder |
| RS150608071 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS150608549 |
FXYD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150609056 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS150610444 |
ROR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachydactyly type B1, Autosomal recessive Robinow syndrome |
| RS150610657 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150613209 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant centronuclear myopathy, Charcot-Marie-Tooth disease dominant intermediate B |
| RS150613320 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Mitochondrial complex I deficiency |
| RS150614630 |
DSG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150614794 |
ALG12
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG12-congenital disorder of glycosylation, ALG12-related disorder |
| RS150617078 |
UBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Johanson-Blizzard syndrome, Johanson-Blizzard syndrome |
| RS150617429 |
EIF2B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, EIF2B2-related disorder |
| RS150617550 |
DVL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150618729 |
TFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemochromatosis, Hemochromatosis type 3 |
| RS150618811 |
RHOBTB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150619347 |
ARV1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 38 |
| RS150619709 |
ACADSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of 2-methylbutyryl-CoA dehydrogenase, Deficiency of 2-methylbutyryl-CoA dehydrogenase |
| RS150622293 |
CR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency, common variable |
| RS150622626 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatocellular carcinoma, Glycogen storage disease |
| RS150623081 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
ANKRD26-related disorder, Inborn genetic diseases |
| RS150624399 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150624408 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS150626228 |
BOLA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple mitochondrial dysfunctions syndrome 2, BOLA3-related disorder |
| RS150626749 |
KCNK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary hypertension, primary |
| RS150627172 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |
| RS150629342 |
RSPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 24 |
| RS150629598 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS150629697 |
PROP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary hormone deficiency, combined |
| RS150629840 |
CCAR2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150630090 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS150630318 |
WDR11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150630640 |
SMARCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nicolaides-Baraitser syndrome, Nicolaides-Baraitser syndrome |
| RS150631268 |
ADAMTSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectopia lentis 2, isolated |
| RS150631550 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Intellectual disability |
| RS150631940 |
BLM
|
Health Risk |
Pathogenic |
Bloom syndrome, Bloom syndrome |
| RS150632241 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS150633177 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS150633775 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, Central core myopathy |
| RS150634562 |
AIRE
|
Health Risk |
Conflicting classifications of pathogenicity |
Polyglandular autoimmune syndrome, type 1 |
| RS150635097 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS150636017 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Autoinflammatory syndrome |
| RS150636501 |
RLBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Pigmentary retinal dystrophy |
| RS150636811 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS150637770 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, Inborn genetic diseases |
| RS150637771 |
TCOF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Treacher Collins syndrome 1, TCOF1-related disorder |
| RS150637898 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS150638029 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |
| RS150638770 |
CHRNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome, Lethal multiple pterygium syndrome |
| RS150639035 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
| RS150639487 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness autosomal dominant 2, Retinitis pigmentosa |
| RS150640353 |
KLHL7
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS150640883 |
SOST
|
Health Risk |
Conflicting classifications of pathogenicity |
Sclerosteosis 1, Sclerosteosis 1 |
| RS150642468 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150642676 |
CNGB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 3, Severe early-childhood-onset retinal dystrophy |
| RS150642856 |
MMUT
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to complete methylmalonyl-CoA mutase deficiency |
| RS150642992 |
BMPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary hypertension, primary |
| RS150643803 |
RAB3GAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Warburg micro syndrome 2, Martsolf syndrome |
| RS150644209 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, LAMA2-related disorder |
| RS150644405 |
FLG
|
Health Risk |
Pathogenic |
— |
| RS150645079 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Charcot-Marie-Tooth disease type 2 |
| RS150645228 |
FLVCR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150645662 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Somatotroph adenoma |
| RS150645738 |
AMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscle AMP deaminase deficiency, Muscle AMP deaminase deficiency |
| RS150646039 |
SDCCAG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS150646107 |
BCAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150646335 |
NUS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, type IAA |
| RS150646872 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS150647141 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |